SoftBank Vision Fund L.P., 10% Owner at Roivant Sciences Ltd. (ROIV), sold 12,000,000 shares at $8.00 ($96.0M) on 2023-03-20, disclosed to the SEC on 2023-03-22.
Open-market sale of $96.0M ROIV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| UROV | BUY | 2019-05-29 | $110K | — | Filing → |
| UROV | BUY | 2019-05-23 | $248K | — | Filing → |
| AXON | BUY | 2019-03-19 | $20.0M | — | Filing → |